US Edition
Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results
- Electra.aero, Surf Air Mobility, and Virginia Tech completed the first public demonstrations of Electra's Ultra Short aircraft capabilities in August 2025 in Virginia.
- These demonstrations followed years of development and partnerships aimed at commercializing hybrid-electric aircraft to improve regional air mobility and reduce reliance on large airports.
- The demonstrations showcased aircraft takeoffs and landings within 150 feet using hybrid-electric propulsion and highlighted operational flexibility in real-world non-airport environments.
- Electra's EL9 Ultra Short has received pre-orders totaling more than 2,200 units from upwards of 60 operators and is reported by CEO Marc Allen and Eric Paterson to function at one-third the expense of helicopters while generating noise at a level 100 times lower.
- This milestone advances Electra's commercialization efforts and suggests Ultra Short technology could transform aviation by enabling faster, quieter, and more accessible regional air travel.
103 Articles
103 Articles
Radiate Holdco, LLC Releases Second Quarter 2025 Financial Results
PRINCETON, N.J., Aug. 14, 2025 /PRNewswire/ -- Radiate Holdco, LLC ("Radiate") announced today that it released its Second Quarter 2025 financial results on its secure investor website. The financial results were provided in accordance with the terms of the Indentures…
TILT Holdings Reports Second Quarter 2025 Results
This news release contains forward-looking information and statements (together, “forward-looking information”) under applicable Canadian and U.S. securities laws which are based on current expectations. Forward-looking information is provided for the purpose of presenting information about TILT management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purpo…
Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results
SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended June 30, 2025.
Coverage Details
Bias Distribution
- 52% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
